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Background: The Wnt signaling pathway is involved in the control of cell proliferation and differentiation during
skeletal muscle development. Secreted frizzled-related proteins (SFRPs), such as SFRP1, function as inhibitors of Wnt
signaling. MicroRNA-1/206(miRNA-1/206) is specifically expressed in skeletal muscle and play a critical role in
myogenesis. The miRNA-mRNA profiles and bioinformatics study suggested that the SFRP1 gene was potentially
regulated by miRNA-1/206 during porcine skeletal muscle development.
Methods: To understand the function of SFRP1 and miRNA-1/206 in swine myogenesis, we first predicted the
targets of miRNA-1/206 with the TargetScan and PicTar programs, and analyzed the molecular characterization
of the porcine SFRP1 gene. We performed a temporal-spatial expression analysis of SFRP1 mRNA and miRNA-206 in
Tongcheng pigs (a Chinese indigenous breed) by quantitative real-time polymerase chain reaction, and conducted the
co-expression analyses of SFRP1 and miRNA-1/206. Subsequently, the interaction between SFRP1 and miRNA-1/206 was
validated via dual luciferase and Western blot assays.
Results: The bioinformatics analysis predicted SFRP1 to be a target of miRNA-1/206. The expression level of the SFRP1
was highly varied across numerous pig tissues and it was down-regulated during porcine skeletal muscle development.
The expression level of the SFRP1 was significantly higher in the embryonic skeletal compared with postnatal skeletal
muscle, whereas miR-206 showed the inverse pattern of expression. A significant negative correlation was
observed between the expression of miR-1/206 and SFRP1 during porcine skeletal muscle development (p <0.05).
Dual luciferase assay and Western-blot results demonstrated that SFRP1 was a target of miR-1/206 in porcine iliac
endothelial cells.
Conclusions: Our results indicate that the SFRP1 gene is regulated by miR-1/206 and potentially affects skeletal muscle
development. These findings increase understanding of the biological functions and the regulation of the SFRP1 gene
in mammals.
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The Wnt signaling pathway plays an essential role during
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it regulates the expression of myogenic regulatory factors,* Correspondence: tangzhonglin@caas.cn
†Equal contributors
1Key Laboratory of Farm Animal Genetic Resources and Germplasm
Innovation of Ministry of Agriculture, Institute of Animal Science, Chinese
Academy of Agricultural Sciences, Beijing 100193, P.R. China
2Agricultural Genome Institute at Shenzhen, Chinese Academy of Agricultural
Sciences, Shenzhen 518124, P.R. China
Full list of author information is available at the end of the article
© 2015 Yang et al.; licensee BioMed Central. T
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.which are essential for myogenic lineage progression and
the formation of functional multinucleated myotubes [3,4].
The Wnt signaling pathway also simultaneously promotes
myogenic and inhibits adipogenic differentiation within pri-
mary adult myoblasts [5]. During adult skeletal muscle re-
generation, the Wnt signaling pathway is involved in
satellite cell proliferation and differentiation as well as in
self-renewal [6]. Secreted frizzled-related protein 1 (SFRP1)
is a member of the SFRP family that inhibits Wnt signaling
[7]. The SFRPs inhibit Wnt receptor binding to down-
regulate pathway signaling during development [8]. Thehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and human genomes [9], which play important roles in de-
velopmental and oncogenic processes [10,11]. The addition
of recombinant SFRP1 and SFRP2 to C2C12 or primary sat-
ellite cells may inhibit myotube formation; therefore, SFRP1
and SFRP2 act to prevent myoblasts from entering the ter-
minal differentiation process [12]. Additionally, SFRP1 also
controls vascular cell proliferation in vitro and in vivo [13].
MicroRNAs are a class of small, single-stranded, noncod-
ing RNA (~21-24 nt in length) that occur in the genomes
of plants and animals. They function post-transcriptionally
by interacting directly with 3′-UTRs of mRNAs to repress
their expression by translational inhibition, mRNA degrad-
ation, or both [14,15]. miRNAs are involved in multiple bio-
logical processes, including development [16], cancer
[17,18], cell differentiation [19], apoptosis [20], and metab-
olism [21]. Moreover, miRNAs play a modulatory role in
the development and growth of skeletal muscles [22]. Three
miRNAs, miRNA-1, −133 and −206, are specifically
expressed in muscle and are considered to be myomiRs
[23,24]. miRNA-1 and miRNA-133 are expressed in both
cardiac and skeletal muscles [25] and miRNA-206 is only
expressed in skeletal muscle [26]. miRNA-1 and miRNA-
206 regulate skeletal muscle satellite cell proliferation and
differentiation by repressing the paired box 7 (Pax7) gene
[27]. These two miRNAs also promote myogenesis by tar-
geting the histone deacetylase 4 (HDAC4) and the largest
subunit of DNA polymerase α (Pola1), whereas miRNA-
133 may inhibit myoblast differentiation and increase prolif-
eration by repressing the serum response factor (SRF)
[28,29]. Our recent study documented that miRNA-1 and
miRNA-206 were abundantly and specifically expressed in
porcine skeletal muscle [30].
In our previous study, we conducted mRNA and
miRNA transcriptome profiling on prenatal skeletal
muscle of Tongcheng pigs at 33, 65 and 90 days post-
coitus (dpc) using the microarray analysis. Integrated
analysis of miRNA and mRNA suggested that SFRP1
and miRNA-1/206 exhibited opposite expression pat-
terns and potentially interacted during prenatal skeletal
muscle development. To further explore the biological
functions and regulatory mechanisms of SFRP1 gene and
miRNA-1/206 in porcine muscle development, we ana-
lyzed the temporal and spatial expression patterns of
miRNA-206 and SFRP1 in prenatal and postnatal skel-
etal muscle at 20 developmental stages. Subsequently,
the interaction between SFRP1 and miRNA-1/206 was
validated using dual luciferase and Western-blot assays.
Methods
Bioinformatics analysis
The public TargetScan (http://www.targetscan.org/) and
PicTar (http://pictar.mdc-berlin.de/cgi-bin/PicTar_verte-
brate.cgi) programs were used to predict the targets andbinding sites of miRNA-1/206. A DAVID functional an-
notation analysis (http://david.abcc.ncifcrf.gov/) was per-
formed to investigate the potential biological function
and KEGG pathways of miRNA-1/206 targets [31]. The
mRNAs and protein sequences of the SFRP1 from differ-
ent species were retrieved from the GenBank database.
The isoelectric point and molecular weight of porcine
SFRP1 were predicted using the ExPASy website (http://
web.expasy.org/compute_pi/). The alignment of SFRP1se-
quences and generation of the phylogenetic tree were per-
formed by MEGA5.05 [32]. The protein localization sites
in cells and the porcine SFRP1 protein domains were pre-
dicted by the PSORT program using the K-NN method
(http://psort.nibb.ac.jp/) and SMART software (http://
smart.embl-heidelberg.de/), respectively.
Animal sample collection
The Biological Studies Animal Care and Use Committee
of Hubei Province, P.R. China approved the animal pro-
cedures. In this study, all animals were sacrificed at a
commercial slaughterhouse according to approved pro-
cedures. Seven tissue samples, including heart, liver,
spleen, lung, kidney, small intestine and longissimus
dorsi muscle, were collected from three adult Tongcheng
pigs (postnatal days 240) for the spatial expression ana-
lysis. Longissimus dorsi muscle samples were collected
from Tongcheng pigs for dynamic expression profile
analysis and were sampled at 20 developmental stages,
including embryonic days 33, 40, 45, 55, 60, 70, 75, 80,
85, 90, 95, 100, and 105 (abbreviated as E33, E40, E45,
E55, E60, E70, E75, E80, E85, E90, E95, E100, and E105)
and postnatal days 0, 20, 40, 60, 100, 120 and 160 (ab-
breviated as D0, D20, D40, D60, D100, D120 and D160).
At each time point, samples from three pigs were har-
vested as biological replicates. All samples were stored
immediately in liquid nitrogen until further use.
Isolation of RNA and reverse transcription
Total RNA was extracted according to the manufacturer’s
protocol using Trizol Reagent (Invitrogen, Carlsbad, CA,
USA). The total RNA concentration was determined by
spectrophotometry, and sample integrity and quality were
estimated by agarose gel electrophoresis and the OD260/
OD280 ratio (high quality being between 1.8 and 2.0). Gen-
omic DNA was removed using DNase I enzyme. One
microgram of total RNA was reverse-transcribed into
cDNA in a final volume of 20 μl using a RevertAid First
Strand cDNA Synthesis Kit (MBI Fermentas, Vilnius,
Lithuania) according to the manufacturer’s protocols. The
cDNA was stored at −20°C.
Real-time quantitative PCR
The expression of SFRP1 mRNA and miRNA-206 was
detected by real-time quantitative polymerase chain
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was obtained from the miRBase database (Accession ID:
MI0013084) (http://www.mirbase.org/) [33]. Specific
stem-looped primers were designed according to a previ-
ous study [34]. The gene-specific primers used for quan-
titative PCR are listed in Table 1. Each real-time PCR
reaction was performed in a final volume of 20 μL con-
taining 10 μL SYBR Premix Ex Taq (2×), 0.4 μL Rox Ref-
erence DyeII (50×)(TaKaRa, Dalian, China), 0.4 μL
forward primer(10 μM), 0.4 μL reverse primer(10 μM),
2.0 μL template cDNA and 6.8 μL dH2O. PCR amplifica-
tion was performed on a 7500 FAST Real-Time PCR
System (Applied Biosystems, Foster City, CA, USA)
under the following cycling conditions: 30 s at 95°C,
followed by 40 cycles at 95°C for 5 s, 60°C for 34 s. Por-
cine GAPDH and the U6 genes were amplified as refer-
ence controls for SFRP1 and miRNA-206, respectively.
Each reaction was performed in triplicate, and the data
were analyzed by the 2-△△Ct method using 7500 System
SDS software V 1.4.0.
Plasmid construct
A 230 bp fragment encompassing a partial SFRP1 3′-
UTR containing miRNA-1/206 binding sites was cloned
from a Tongcheng pig using gene-specific primers
(Table 1). This fragment was inserted downstream of the
Renilla luciferase open reading frame in the psiCheck-2
vector (Promega, USA) using NotI and XhoI restriction
sites. The mutant SFRP1 3′-UTR sequence, which had a
7 bp deletion in the binding site, was cloned by bridge
PCR and inserted into the final destination vectors to
construct the mutated vector. To construct the SFRP1Table 1 Primer information







SFRP1 (mut-1) F: CTCGAGTTCTTCTAGTTCCT
R: ACAACAACACACCAATGA







U6-RT CGCTTCACGAATTTGCGTGTCover-expression vector, a 247 bp fragment containing
the coding sequence of SFRP1 was cloned into the NheI
and XhoI restriction sites of the psiCHECK-2 vector to
replace the Renilla coding sequence, resulting in SFRP1-
CDS-3′-UTR-psiCHECK-2. All the PCR products were
confirmed by direct sequencing.
Cell culture and dual luciferase reporter assay
Porcine iliac endothelial cells (PIECs; obtained from the
Institute of Biochemistry and Cell Biology, Chinese
Academy of Sciences, P.R. China) were cultured in
Dulbecco’s modified Eagle's medium with high glu-
cose (Gibco, Invitrogen, Carlsbad, CA, USA), supple-
mented with 10% fetal bovine serum (Gibco), 1%
glutamine, and 1% penicillin/streptomycin (Gibco).
The cells were incubated at 37°C in 5% CO2. Chem-
ically synthesized miRNA-1/206 or the negative con-
trol duplexes (Gene Pharma, Shanghai, China) were
transfected into the PIECs in combination with a lu-
ciferase reporter containing wild-type or mutant
SFRP1 3′UTR using Lipofectamine 2000 reagent
(Gibco) in 24-well plates. Each transfection was per-
formed in triplicate. At 48 h after transfection, all
the cells were harvested. Renilla and Firefly luciferase ac-
tivities were measured with the Dual Luciferase Assay Sys-
tem (Promega, Madison, WI, USA) in a TD-20/20
luminometer (Turner Biosystems, Sunnyvale, CA, USA).
The Renilla luciferase signal was normalized to the Firefly
luciferase signal. The normalized Renilla luciferase activity
was compared with the control, miRNA-1/206 and the

















Table 2 Significantly enriched KEGG pathways of target
genes

























6 2.23 0.049 BDNF, YWHAZ,
RAP1A, RAP1B,
NGFR, CALM2
SFRP1 is involved in the Wnt signaling pathway and selected for further study.
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PIECs, transfected with the indicated plasmids, were
harvested at 48 h after transfection, and washed twice in
phosphate-buffered saline. The total protein was ex-
tracted using M-PER Mammalian Protein Extraction Re-
agent (Thermo Scientific, USA). Protein concentrations
were measured with a Pierce BCA Protein Assay Kit
(Thermo Scientific, USA) according to the manufac-
turer’s instructions. Western-blot analysis was performed
as follows: 20 μg of protein per lane was resolved by so-
dium dodecyl sulfate polyacrylamide gel electrophoresis
and transferred to polyvinylidene difluoride (PVDF)
membranes (Millipore). The PVDF membranes were
probed with primary antibodies (Santa Cruz Biotech.,
Santa Cruz, CA, USA) at a 1:1,000 dilution and with β-
actin (Santa Cruz Biotech., Santa Cruz, CA, USA) at a
1:5,000 dilution as a control. The membranes were further
incubated with an horseradish-peroxidase-conjugated sec-
ondary antibody (Zymed, San Diego, CA, USA) at a
1:10,000 dilution.
Results
Target prediction of miRNA-1/206 and bioinformatic
analysis
The candidate targets of miRNA-1/206 were predicted
using TargetScan and PicTar programs. 258 candidate
targets were predicted by both programs. To explore the
biological function of the candidate genes, a DAVID
functional annotation analysis was performed using the
thresholds EASE adjusted to p < 0.05. The Gene Ontol-
ogy (GO) analysis revealed that these targets were sig-
nificantly enriched in the regulation of transcription,
positive regulation of macromolecule metabolic pro-
cesses, positive regulation of nitrogen compound meta-
bolic processes, positive regulation of cellular
biosynthetic processes and other biological processes
(Figure 1). KEGG pathway analysis showed that these
targets were significantly enriched in four pathways (p
<0.05), which were SNARE interactions in vesicular
transport, the Wnt signaling pathway, small cell lung
cancer and the Neurotrophin signaling pathway (Table 2).Figure 1 Top 10 GO biological process terms significantly enriched in
a DAVID functional annotation program.Seven putative targets, including CCND1, SFRP1,
CCND2, PPP2R5A, NFAT5, DAAM1 and FZD7, partici-
pated in the Wnt signaling pathway. Therefore, the
SFRP1 gene, which was predicted to be a target of
miRNA-1/206 and was involved in the Wnt signaling
pathway, was selected for further study.
Sequence analysis of the porcine SFRP1 gene
The SFRP1 protein sequences (Accession ID:
XM_003359868.3) were retrieved from the GenBank
database. First, the amino acid sequence of porcine
SFRP1 was compared with those of the human, mouse
and rat, and the alignment results showed that the pro-
tein sequence of the pig had a six amino acid depletion.
The porcine SFRP1 polypeptide exhibited 96.09%,
94.26% and 93.31% similarity with the human, mouse
and rat homologs, respectively (Figure 2). Based on the
phylogenetic tree analysis, the protein sequence of the
pig was closely related to that of cow, while the rat and
mouse formed another closely related group, and these
four species formed a group with the humans (Figure 3A).
SMART software was used to predict SFRP1 proteinfor target genes of miRNA-1/206. GO analysis was conducted with
Figure 2 Comparison of porcine SFRP1 sequence (GenBank accession ID: XP_003359916.2) with those of human (GenBank accession
ID: NP_003003.3), mouse (GenBank accession ID: NP_038862.2) and rat (GenBank accession no. NP_001263641.1) sequence. Shading
shows identical and similar amino acid residues among the four species. Common structural domains are indicated by boxes including a Frizzled
domain and a Netrin C-terminal domain.
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Frizzled domain and a Netrin C-terminal domain
(Figure 3B). The sites of SFRP1 protein localization
had a 44.4% possibility of being extracellular, a
22.2% possibility of being cytoplasmic and a 22.2%
possibility of being in the endoplasmic reticulum.
Additionally, the theoretical isoelectric point (pI)
and molecular weight (Mw) of SFRP1 were 9.05 and
34.79 KDa, respectively.Distribution of porcine SFRP1 mRNA and miRNA-206 in
tissues
The expression of SFRP1 and miRNA-206 was mea-
sured in seven tissues from adult Tongcheng pigs. The
SFRP1 gene was highly expressed in the kidney, liver,
lung, spleen and small intestine, moderately expressed
in the heart, and weakly expressed in the longissimus
dorsi muscle (Figure 4A). However, miRNA-206 was
abundantly expressed in the longissimus dorsi muscle
and heart, and was weakly expressed in the other tis-
sues (Figure 4B).Figure 3 Phylogenetic tree and domains of porcine SFRP1 protein. (A
accession numbers of those sequences are as follows: pig, XP_003359916.2
mouse, NP_038862.2, and chicken, NP_989884.1. (B) Porcine SFRP1 protein
domain and a Netrin C-terminal domain.Developmental expression of porcine SFRP1 mRNA and
miRNA-206
We collected the longissimus dorsi muscle from 20 pre-
natal and postnatal developmental stages of Tongcheng
pigs. Quantitative real-time PCR indicated that SFRP1
was highly expressed at the E33 stage, and was then
down-regulated from E33 to E55. It was then up-
regulated from E55 to E70 and down-regulated from
E70 to E85. Subsequently, it was up-regulated from the
E85 to E95, and then down-regulated again from E95 to
D0. The expression of SFRP1 was maintained at a stable
low level in postnatal skeletal muscle. In postnatal myo-
genesis, SFRP1 was consistently expressed from days 0
to 40. Subsequently, it decreased and reached a mini-
mum at D100 (Figure 4C). The expression of miRNA-
206 was weak in skeletal muscle in the early embryonic
stages, but then remained stable with high levels of ex-
pression in the remaining prenatal stages, although some
fluctuations occurred. The expression level of miRNA-
206 reached a peak at E100. In postnatal muscle,
miRNA-206 was down-regulated from D0 to D40 and
was up-regulated from D40 to D100 (Figure 4D).) Phylogenetic tree of SFRP1 from different species. The GenBank
; human, NP_003003.3; cattle,NP_776885.1; rat, NP_001263641.1;
domains. The porcine SFRP1 precursor protein contains a Frizzled
Figure 4 Relative expression of SFRP1and miRNA-206 in the different tissues and in skeletal muscle during development of Tongcheng
pigs. (A) Tissue distribution of SFRP1 in the adult Tongcheng pig. (B) Tissue distribution of miRNA-206 in the adult Tongcheng pig. (C) Relative
expression of SFRP1 mRNA and (D) miRNA-1/206 in porcine skeletal muscle from Tongcheng pigs at different developmental stages (20 stages).
miRNA-1 expression in Tongcheng pigs is cited from Tang et al. [35]. The values are the average (±SE) levels of SFRP1 mRNA and miRNA-1/206
from three independent experiments normalized to GAPDH and U6, respectively. In each group, the lowest expression value was arbitrarily set to
0 by log10 transformation to evaluate the relative expression levels.
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Tang et al. have explored the spatial and dynamic ex-
pression of miRNA-1 in the Tongcheng pig (Figure 4D)
[35]. According to their study and this study, miRNA-
1 and miRNA-206 were abundantly expressed in skel-
etal muscle and weakly expressed in other tissues. In
contrast, SFRP1 was expressed at very low levels in
adult skeletal muscle. The co-expression analysis re-
vealed that the SFPR1 mRNA was significantly nega-
tively correlated with miRNA-1 (Pearson’s RSFRP1/
miRNA-1 = −0.928, p value = 0.003) (Figure 5A) and
miRNA-206 (Pearson’s RSFRP1/miRNA-1 = −0.922, p value =
0.003) (Figure 5B) at the mRNA level in different tissues
adult tissues.
During skeletal muscle development, SFPR1 had a
higher expression level in the prenatal stages than in
the postnatal stages. However, in contrast to SFRP1,
miRNA-1/206 exhibited a relatively higher level of
expression in postnatal muscle compared with pre-
natal muscle. SFRP1 mRNA was significantly nega-
tively correlated with miRNA-1/206 [Pearson’s
RSFRP1/miRNA-1 = −0.445, pvalue = 0.032 (Figure 5C);
Pearson’s RSFRP1/miRNA-206 = −0.480, p value = 0.049
(Figure 5D)]. These results indicated that SFRP1 ex-
pression might be regulated by miR-1/206 in pigs.SFRP1 is a putative target of microRNA-1/206
The prediction from the miRNA-mRNA profiles and
bioinformatics suggested that SFRP1 was potentially a
miRNA-1/206 target in pigs. In the 3′-UTR region of
SFRP1 mRNA, a putative binding site was identified
(7 bp conserved homology) (Figure 6A). The seed se-
quence of miRNA-1/206 and the target-binding site
between SFRP1 and miRNA-1/ 206 were highly con-
served across mammals (Figure 7).
To validate whether SFRP1 was directly targeted
by miRNA-1/206 in pigs, we constructed the
psiCheck2-SFRP1-3′-UTR , a luciferase reporter vec-
tor. Subsequently, miRNA-1and miRNA-206 mimics
and a normal control (NC) were co-transfected into
PIECs, and luciferase activity was detected. The
miRNA-1 mimic-transfected group exhibited 68.29%
less luciferase activity compared with the NC group
(p < 0.01) and the miRNA-206 mimic-transfected
group exhibited 71.25% less luciferase activity compared
with the control (p < 0.01) (Figure 8). To further validate
the specific target site, the binding region of the SFRP1 3′-
UTR was mutated by bridge PCR (Figure 6B). The lucifer-
ase activity of the psiCHECK-2-SFRP1–3′-UTR (mut) was
not significantly decreased by both the miRNA-1 and
miRNA-206 mimics (12.39% of control for the miRNA-1
Figure 5 Correlation analyses of miRNA-1/206 and SFRP1 expression. (A) Pearson’s correlation between SFRP1 and miRNA-1 expression in
different tissues. (B) Pearson’s correlation between SFRP1 and miRNA-206 expression in different tissues. (C) Pearson’s correlation between SFRP1
and miRNA-1 expression during skeletal muscle development. (D) Pearson’s correlation between SFRP1 and miRNA-206 expression during skeletal
muscle development.
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miRNA-206 mimic-transfected group) (p >0.05) (Figure 8).
Then, we determined whether SFRP1 was affected by
miRNA-1/206 at the protein level. The overexpression
vector of SFRP1 was constructed and transfected into
PIECs, and the quantitative real-time PCR (qPCR) re-
sults showed that the expression of SFRP1 was increased
approximately 16-fold compared with the NC group.
This result indicated that the SFRP1 overexpression vec-
tor was successful (Figure 9A). The porcine SFRP1-
CDS-3′-UTR-psiCHECK-2 vector was constructed, and
it was co-transfected with miRNA-1 and miRNA-206
mimics in PIECs. The Western blot results showed that
the protein level of SFRP1 in the groups containing
miRNA-1/206 mimics was decreased compared with the
NC group (Figure 9B). These results suggested that the
SFRP1 gene was a target of miRNA-1/206.
Discussion
We predicted the targets of miRNA-1/206 with the Tar-
getScan and PicTar programs. Among the putative tar-
gets, many genes had been validated by previous studies,
such as HDAC4 [29], GJA1, KCNJ2 [36], Pola1 [28], and
Met [37]. However, all these results were based on myo-
blast C2C12 cells in vitro. Few reports have considered
miRNA-1/206 targets during skeletal muscle developmentin vivo, particularly in pigs. To discover potential targets
of miRNA-1/206 during swine myogenesis, we conducted
GO and KEGG pathway analyses of targets based on the
prediction data. The results suggested that these targets
were significantly enriched in the Wnt signaling pathway
(p < 0.05). Wnts signaling proteins are secreted proteins
that function in differentiation, embryonic development
and cell proliferation [38]. The Wnt pathways play an im-
portant role in the formation of muscle fibers during pre-
natal [39] and postnatal myogenesis with the activation of
stem cells in the adult muscles [40,41]. SFRP1, a secreted
antagonist of the Wnt-Frizzled pathway, was predicted to
be a target of miRNA-1/206 and to participate in the Wnt
signaling pathway. The expression of SFRP1 mRNA
was up-regulated in muscle regeneration [42] and in
skeletal muscle after denervation [43]. Additionally,
an impairment of the Wnt-Frizzled pathway via
SFRP1 over-expression controlled proliferation and
neovascularization after muscle ischemia [13]. A com-
parison of the amino acid sequence of pig SFRP1
with those of human, rat and mouse demonstrated
remarkably high similarity across species, and the
frizzled domain and netrin C-terminal domain were
especially highly conserved.
Previous studies reported SFRP1 expression at the
mRNA level in various tissues, such as the brain, kidney
Figure 6 SFRP1 3′-UTR has miR-1/206 target binding sites. (A) SFRP1 was predicted as a target of microRNA-1/206. (B) Schematic of the predicted
miRNA-1 and miRNA-206 binding sites (underlined) in the 3′ UTR of SFRP1. The binding site region was deleted in the mutant 3′ -UTR reporters.
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the adult and during embryogenesis [7,44]. Moreover,
SFRP1 was weakly expressed in matured skeletal muscles
[45]. The qPCR results for SFRP1 in various adult por-
cine tissues were mostly consistent with these reports.
These results indicated that SFRP1 had almost no antag-
onistic effect in adult skeletal muscle. Postnatal muscle
growth is largely determined by the total number of fi-
bers, which is determined by two major waves of fiber
generation before birth: primary muscle fiber formation
at 35–60 dpc and assemblage of secondary muscle fibers
at 54–90 dpc [46-48]. The SFRP1 gene was down-regulated
in skeletal muscle from E33 to E55 in Tongcheng pigs, indi-
cating that SFRP1 was primarily involved in the formation
of primary muscle fibers. We also found that the expression
of SFRP1 was higher in embryonic skeletal muscle com-
pared with postnatal skeletal muscle. miRNA-206, mean-
while, was abundantly expressed in skeletal muscle and
heart, and up-regulated from pre- to postnatal-stage skeletalFigure 7 Predicted miRNA-1 and miRNA-206 binding sites (highlighte
(A) Seed sequence of miRNA-1 showing species conservation. (B) Seed seq
(highlighted in red) in the 3′-UTR of SFRP1 showing species conservation.muscle. These results demonstrated that miR-206 plays a
key role in skeletal muscle development in pigs. SFRP1 pri-
marily affected skeletal muscle development in embryonic
stages. Wnts signaling contributes to the overall process of
myogenesis by activating myogenic regulatory factor genes
such as Myf5 and MyoD [49]. miRNA-1/206 promoted
skeletal muscle satellite cell proliferation and differentiation
[27] and SFRP1 might inhibit myoblast differentiation [12].
The temporal expression patterns of miRNA-1/206 and
SFRP1 in Tongcheng pigs were consistent with these previ-
ous findings.
The mRNA-miRNA co-expression correlation ana-
lysis was reported to identify the putative targets of
miRNA [50,51], and this method could improve the
positive rate for identifying the mRNA target genes
of miRNA. miRNA-1 and miRNA-206 were abun-
dant in the postnatal stages and were at low levels
in the prenatal stages of muscle development, while
SFRP1 exhibited an opposite expression patterns.d in red) in the 3′-UTR of SFRP1 showing species conservation.
uence of miRNA-206 showing species conservation. (C) Binding sites
Figure 8 Validating SFRP1 as a positive target for miRNA-1 and miRNA-206. Cotransfection of porcine pre-miRNA-1 (A) and pre-miRNA-206
(B) or control and porcine SFRP1 UTR-derived psiCHECK-2 construct or mutant in PIEC cells. Renilla activity at 48 h post-transfection shows a significant
decrease in normalized values compared with the control and mutant. Three replicates were performed for each group. **Indicates a p-value of less
than 0.01 in Student’s t-test.
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nificantly negatively correlated with miRNA-1/206
(p < 0.05), and these results indicate that SFRP1 is
potentially regulated by miRNA-1/206.
The interaction between SFRP1 and miRNA-1/206 in
pigs has not been previously reported. This study dem-
onstrated that SFRP1 expression was regulated by
miRNA-1/206. The SFRP1 3′-UTR sequence around the
miRNA-1/206 target sites and the seed sequence of ma-
ture miRNA-1/206 are well conserved in mammals,
which suggests that the target region is important in
SFRP1 regulation and that the regulation of SFRP1 by
miRNA-1/206 may also exist in other species. Similar re-
sults were observed in other miRNA studies [30,52].
The luciferase activity of psiCHECK-2 containing
the SFRP1 3′-UTR sequence was significantly de-
creased by co-transfection with miRNA-1/206
mimics (p < 0.05). However, with the SFRP1 3′-UTR
mutant sequence, activity was not significantly de-
creased (p > 0.05). These results indicated that the
target binding site was specific and unique in pigs,
and that miRNA-1/206 might repress SFRP1 expres-
sion by degrading the mRNA transcripts. We proposeFigure 9 The miRNA-1 and miRNA-206 regulate SFRP1 at the protein
indicates overexpression of SFRP1 48 h after transfection. (B) miRNA-1 and mi
SFRP1 was normalized against β-actin.that SFRP1 is regulated by miRNA-1/206, is >involved
in the proliferation of muscle cells, and affects pre-
natal skeletal muscle development. Moreover, we ex-
plored the interactions between SFRP1 and miRNA-
1/206 at the protein level, and Western-blot analysis
confirmed that SFRP1 was significantly down-
regulated by miRNA-1/206.Conclusions
In summary, we predicted the target genes of miRNA-1/206
and performed a functional annotation of the target genes.
We performed a molecular characterization analysis of the
porcine SFRP1 gene,, which was one of the predicted targets
for miRNA-1/206. We also explored the spatial-temporal
profile of SFRP1 mRNA and miRNA-206 in adult tissues
and in skeletal muscle tissues during development in Tong-
cheng pigs. The results indicated that SFRP1 was primarily
involved in prenatal skeletal muscle development. Finally, we
verified that porcine SFRP1 was a target of miRNA-1/206
using dual luciferase and Western blot assay. These results
increase our understanding of the biological functions of
SFRP1 and miRNA-1/206 in skeletal muscle development.level. (A) Overexpression of porcine SFRP1 in PIEC cells. Histogram
RNA-206 down-regulated the SFRP1 at the protein level. The expression of
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